NGS-based RNA-seq Market by Products & Services (Sample Preparation, Consumables, Bioinformatics), Technology (SBS, SMRT), Application (De novo, Transcriptome Epigenetics, Small RNA), End User (Resear...
The 3D cell culture market is expected to reach USD 1,720.3 Million by 2022 from USD 570.4 Million in 2016 growing at a CAGR of 20.3%
The global eye exam equipment market is projected to reach USD 3.05 Billion by 2022 from USD 2.29 Billion in 2017, at a CAGR of 6.0%
Temperature Monitoring Systems Market by Product (Monitor, Strip, Handheld, Wireless, Pyrometer, IR, Camera, Fiber Optic), Application (Cold Storage, Greenhouse, Life science, Patient), End user, and...
The medical terminology software market is projected to reach USD 1,786 million by 2024 from USD 707 million in 2019, at a CAGR of 20.4%
Immuno Oncology Assays Market by Product (Consumables, Software), Technology (Immunoassay, Flow Cytometry, PCR, Next Generation Sequencing), Indication (Lung Cancer, Colorectal Cancer), Application (R...
The global hydrophobic interaction chromatography market is projected to reach USD 418.2 million in 2023 from USD 271.0 million in 2017, at a CAGR of 7.5%.
The global cranial fixation and stabilization systems market is valued at USD 1.06 Billion in 2016 and is projected to reach USD 1.74 Billion by 2022, at a CAGR of 8.7%.
Know the detailed information regarding the major factors influencing the growth of the biosimulation market.
Latin America Infusion Pump Market by Product (Volumetric, Syringe, Feeding, Insulin, PCA Pump), Application (Chemotherapy, Gastroenterology, Diabetes, Pain Management), Setting (Hospital, Ambulatory...
Increasing adoption of 3D cell culture technique in drug discovery is fueling the growth of 3D cell culture market
The overall mass spectrometry market is expected to grow from USD 3.44 billion in 2016 to USD 5.27 billion by 2022, at a CAGR of 7.4%
In the coming years, the global market is expected to witness the highest growth rate in North America
North America is also expected to account for the largest share of the global healthcare provider network management market.
Companion diagnostics have been identified as an area of opportunity for companies seeking to develop innovative products or capabilities in the immuno oncology assays market.
